16018-66-9

Basic information

• Product Name: 1-(p-Bromophenyl)-3-(4,6-dimethyl-2-pyrimidinyl)guanidine
• Synonyms: 1-(p-Bromophenyl)-3-(4,6-dimethyl-2-pyrimidinyl)guanidine;1-(4-bromophenyl)-2-(4,6-dimethyl-2-pyrimidinyl)guanidine;1-(4-bromophenyl)-2-(4,6-dimethylpyrimidin-2-yl)guanidine;GUANIDINE, 1-(p-BROMOPHENYL)-3-(4,6-DIMETHYL-2-PYRIMIDINYL)-;N-(4-Bromophenyl)-3-(4,6-dimethyl-2-pyrimidinyl)guanidine
• CAS NO: 16018-66-9
• Molecular Formula: C13H14BrN5
• Molecular Weight: 320.2
• Mol File: 16018-66-9.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 484.5°C at 760 mmHg
• Flash Point: 246.8°C
• Appearance: /
• Density: 1.51g/cm³
• Vapor Pressure: 1.53E-09mmHg at 25°C
• Refractive Index: 1.667
• PKA: 5.48±0.10(Predicted)
• CAS DataBase Reference: 1-(p-Bromophenyl)-3-(4,6-dimethyl-2-pyrimidinyl)guanidine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(p-Bromophenyl)-3-(4,6-dimethyl-2-pyrimidinyl)guanidine(16018-66-9)
• EPA Substance Registry System: 1-(p-Bromophenyl)-3-(4,6-dimethyl-2-pyrimidinyl)guanidine(16018-66-9)

Safety Data

• Hazardous Substances Data: 16018-66-9(Hazardous Substances Data)

Usage

General Description

1-(p-Bromophenyl)-3-(4,6-dimethyl-2-pyrimidinyl)guanidine is a chemical compound with the molecular formula C14H15BrN6. It is a guanidine derivative that is commonly used as a pesticide and herbicide. Its chemical structure consists of a bromophenyl group attached to a pyrimidinylguanidine moiety, which gives it its pesticidal properties. The compound is effective in controlling a wide range of pests and weeds, making it a popular choice for agricultural and horticultural applications. Additionally, it is known for its high potency and relatively low toxicity to humans and non-target organisms, making it a valuable tool in pest and weed management.

InChI:InChI=1/C13H14BrN5/c1-8-7-9(2)17-13(16-8)19-12(15)18-11-5-3-10(14)4-6-11/h3-7H,1-2H3,(H3,15,16,17,18,19)

Relevant articles and documents

HETEROARYL GUANIDINES ; INHIBITORS OF VIRAL REPLICATION

Compounds of Formula (1), and pharmaceutically acceptable forms thereof, are provided wherein the variables X, Y, Z, Al, R2, R3, R4, R5 and R6 are defined herein. Certain compounds of Formula 1 described herein which possess potent antiviral activity. Certain compounds of Formula (1) that are potent and/ or selective inhibitors of Hepatitis C virus replication. Pharmaceutical compositions containing one or more compounds of Formula (1), or a salt, solvate, or acylated prodrug of such compounds, and one or more pharmaceutically acceptable carriers, excipients, or diluents are also provided. Methods of treating patients suffering from certain infectious diseases by administering to such patients an amount of a compound of Formula (1) effective to reduce signs or symptoms of the disease or disorder are disclosed. These infectious diseases include viral infections, particularly HCV infections. Methods of treating human patients suffering from an infectious disease, but also encompasses methods of treating other animals, including livestock and domesticated companion animals, suffering from an infectious disease. Methods of treatment include administering a compound of Formula (1) as a single active agent or administering a compound of Formula (1) in combination with on or more other therapeutic agent.